| Jun 17 2024 |
USCIS Rescheduling an Existing Biometrics Appointment |
Mintz |
| Jun 14 2024 |
NNI EHS Research Strategy: 2024 Update Available for Public Comment |
Bergeson & Campbell, P.C. |
| Jun 14 2024 |
Supreme Court Rejects Challenge to FDA Approval of Mifepristone on Standing, but the Battle Continues |
Epstein Becker & Green, P.C. |
| Jun 14 2024 |
Client Alert: IARC to Evaluate Automotive Gasoline and Oxygenated Additives in Early 2025 |
Nelson Mullins |
| Jun 14 2024 |
Bump Stock Ruling May Presage Loper—and Clearer Answers to Immigration and Bankruptcy Questions - SCOTUS Today |
Epstein Becker & Green, P.C. |
| Jun 14 2024 |
McDermottPlus Check-Up: June 14, 2024 |
McDermott Will & Schulte LLP |
| Jun 14 2024 |
Supreme Court Unanimously Preserves Access to Mifepristone |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 14 2024 |
Deadline to Register Cosmetic Facilities and List Cosmetic Products Fast Approaches |
ArentFox Schiff LLP |
| Jun 13 2024 |
FDA Wins Mifepristone Case, NLRB Denied Lower Injunctive Relief Standards, and “Trump Too Small” Denied Trademark - SCOTUS Today |
Epstein Becker & Green, P.C. |
| Jun 13 2024 |
Kroger Faces Civil Lawsuit Over Calorie Claims on Bread Products |
Keller and Heckman LLP |
| Jun 13 2024 |
Supreme Court Rejects Challenge to FDA Approval of Mifepristone: Impact on Health Plans |
Proskauer Rose LLP |
| Jun 13 2024 |
New Jersey Takes a “Trip” Towards Therapeutic Psilocybin: Just Don’t Pack Your Bags Yet! |
Norris McLaughlin P.A. |
| Jun 13 2024 |
Registration Opens for June 27, 2024, NNI Webinar on “What’s Next in NanoEHS: Risk Assessment and Risk Management” |
Bergeson & Campbell, P.C. |
| Jun 12 2024 |
EPA Finalizes Risk Management Rules for Asbestos and Methylene Chloride |
Hunton Andrews Kurth |
| Jun 12 2024 |
Nothing Fishy About Whole Foods’ Fish Oil Supplement Product Label |
Proskauer Rose LLP |
| Jun 12 2024 |
Making Sense of a Rare Robinson-Patman Act Plaintiffs’ Verdict |
McDermott Will & Schulte LLP |
| Jun 12 2024 |
FDA to Implement Reorganization of Human Foods Program by October 1 |
Keller and Heckman LLP |
| Jun 11 2024 |
BIPA Amendments + FTC Warns Automakers |
Blank Rome LLP |
| Jun 11 2024 |
Remote Patient Monitoring Innovating Health Tech: A Discussion with Dr. Vipul Kella |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 11 2024 |
FDA Draft Guidance for Bioresearch Monitoring Program Contains General Best Practices for FDA Inspections |
Greenberg Traurig, LLP |
| Jun 11 2024 |
Consumer Reports Finds High Lead Levels in Snacks for Young Children |
Keller and Heckman LLP |
| Jun 11 2024 |
Da Brat and The Latest (Rap) Battle: FDA Expected to Drop Sperm Donation Ban for Gay Men |
ArentFox Schiff LLP |
| Jun 10 2024 |
CODEX ALIMENTARIUS: Outcome of 17th Codex Committee on Toxins and Contaminants in Foods (CCCF17) |
Keller and Heckman LLP |
| Jun 10 2024 |
CODEX ALIMENTARIUS: Outcome of 54th Codex Committee on Food Hygiene (CCFH54) |
Keller and Heckman LLP |
| Jun 6 2024 |
LDT Final Rule Series: Part 1 – Rule Overview |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 6 2024 |
LDT Final Rule Series: Part 2 – Response to the Rule |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 6 2024 |
Federal Circuit Upholds Rifaximin Patent Rulings, Affirms ANDA Approval Restrictions |
Sheppard, Mullin, Richter & Hampton LLP |
| Jun 6 2024 |
For Statutory Equivalents, Even One Means May Be Enough |
McDermott Will & Schulte LLP |
| Jun 6 2024 |
FDA Shares Findings from Multi-Year Pathogen Study |
Keller and Heckman LLP |
| Jun 5 2024 |
Switching Data – A Potent Tonic for Obtaining CMA Clearance at Phase 1 |
Squire Patton Boggs (US) LLP |
| Jun 5 2024 |
NIOSH Science Blog Item Reviews NIOSH Risk Assessment of Engineered Nanomaterials |
Bergeson & Campbell, P.C. |
| Jun 5 2024 |
Cancer Drugs: Deals and Licensing for Antibody-Drug Conjugates |
Foley & Lardner LLP |
| Jun 5 2024 |
APHIS Issues RSR Responses for Modified Corn, Pennycress, Soybean, and Potato Plants |
Bergeson & Campbell, P.C. |
| Jun 5 2024 |
This Week in 340B: May 28 – June 3, 2024 |
McDermott Will & Schulte LLP |
| Jun 5 2024 |
Proposed Cannabis Reschedule Sidesteps State Law Effects |
Wilson Elser Moskowitz Edelman & Dicker LLP |
